PTC Therapeutics
PTCT
PTCT
205 hedge funds and large institutions have $3.52B invested in PTC Therapeutics in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 74 increasing their positions, 82 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
16% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 32
21% less capital invested
Capital invested by funds: $4.46B → $3.52B (-$946M)
Holders
205
Holding in Top 10
6
Calls
$12.3M
Puts
$894K
Top Buyers
| 1 | +$50.8M | |
| 2 | +$32.2M | |
| 3 | +$15.8M | |
| 4 |
N
Natixis
Paris,
France
|
+$9.99M |
| 5 |
D.E. Shaw & Co
New York
|
+$9.25M |
Top Sellers
| 1 | -$41.8M | |
| 2 | -$13.6M | |
| 3 | -$12.2M | |
| 4 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$9.22M |
| 5 |
Goldman Sachs
New York
|
-$9.13M |